(Q108396430)

1

0 references

Leentje Persoons

2

0 references

Els Vanstreels

3

0 references

Sander Jansen

4

0 references

Dominique Van Looveren

5

0 references

Bram Boeckx

6

0 references

Vincent Geudens

7

0 references

Julie De Man

8

0 references

Dirk Jochmans

9

0 references

Joost Wauters

10

0 references

Els Wauters

11

0 references

Bart M. Vanaudenaerde

12

0 references

Johan Neyts

14

0 references

Kai Dallmeier

15

0 references

Hendrik Jan Thibaut

16

0 references

Maarten Jacquemyn

17

0 references

Piet Maes

18

0 references

Dirk Daelemans

Ebola virus entry requires the cholesterol transporter Niemann-Pick C1

19

0 references

publication date

8 March 2021

0 references

published in

Nature Genetics

0 references

volume

53

0 references

issue

4

0 references

page(s)

435-444

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Human aminopeptidase N is a receptor for human coronavirus 229E

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Oxysterol binding protein-related Protein 9 (ORP9) is a cholesterol transfer protein that regulates Golgi structure and function

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Proteomics. Tissue-based map of the human proteome

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Development of one-step, real-time, quantitative reverse transcriptase PCR assays for absolute quantitation of human coronaviruses OC43 and 229E

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Interspecies transmission and emergence of novel viruses: lessons from bats and birds

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

The intricate regulation and complex functions of the Class III phosphoinositide 3-kinase Vps34.

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

What we know about TMEM106B in neurodegeneration

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Critical role of the beta-subunit CDC50A in the stable expression, assembly, subcellular localization, and lipid transport activity of the P4-ATPase ATP8A2

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice.

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Mechanism and medical implications of mammalian autophagy

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Genome-wide CRISPR screen identifies TMEM41B as a gene required for autophagosome formation

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

A pneumonia outbreak associated with a new coronavirus of probable bat origin

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

An interactive web-based dashboard to track COVID-19 in real time

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Origin and evolution of pathogenic coronaviruses

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Virological assessment of hospitalized patients with COVID-2019

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Vitamin D Modulates the Response of Bronchial Epithelial Cells Exposed to Cigarette Smoke Extract

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Beta-binomial modeling of CRISPR pooled screen data identifies target genes with greater sensitivity and fewer false negatives

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Zoonotic origins of human coronaviruses

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Comprehensive Integration of Single-Cell Data

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Cell entry mechanisms of SARS-CoV-2

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Remdesivir for the Treatment of Covid-19 — Final Report

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Inhibitors of VPS34 and lipid metabolism suppress SARS-CoV-2 replication

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Impaired spermatogenesis in COVID-19 patients

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

TMEM41B Is a Pan-flavivirus Host Factor

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Human coronavirus HCoV-229E enters susceptible cells via the endocytic pathway

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2

Human Coronavirus-229E, -OC43, -NL63, and -HKU1 (Coronaviridae)

12 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41588-021-00805-2